This study is the first to show that the risk of a subsequent cardiovascular event rises continually as lipoprotein(a) increases from any level. The study also shows that women and Black ...

Creating animated GIFs used to require downloading special software or using paid online services. Now ChatGPT offers a simple way to turn your images into moving ...

A recent study suggests that measuring levels of apolipoprotein B particles and lipoprotein(a) could help predict the risk of coronary artery disease. These findings could contribute to a shift in ...

High levels of a lipoprotein that is believed to be behind sudden and inexplicable heart attacks and strokes could soon have multiple drugs to treat it Why seemingly healthy Indians in their ...

The phase 2 trial tested the effect of lepodisiran on lipoprotein(a) (Lp(a)). Studies suggest up to 2 billion people globally have elevated Lp(a), which is associated with cardiovascular disease ...

Merck & Co. has agreed to license an investigational oral small molecule lipoprotein(a) inhibitor from Jiangsu Hengrui Pharmaceuticals in a deal potentially worth more than $2 billion to the ...

The FDA cleared a new lipoprotein assay designed to measure lipoprotein(a) in nmol/L. Measuring nmol/L rather than mg/dL may improve diagnostic accuracy during CV risk assessment. Roche announced ...

ApoB100 is a key protein in normal metabolism and in heart disease. Beginning before the protein’s synthesis is completed, it collects cholesterol and fats into particles that allow these ...

Lilly estimates that about 20% of people in the U.S., or 63 million individuals, deal with high levels of Lp(a), which can greatly increase the risk of heart attack and lead to other ...

Authors say findings call for primary prevention strategies to extend beyond traditional 10-year estimates. HealthDay News — A single combined measure of high-sensitivity C-reactive protein (CRP ...